J0737 Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg

Billable / valid for submission HCPCS Release 2026Q3

Short description: Inj, clindamycin (baxter)

Version history

Release	Valid from	Valid to	Description	Billable
2026Q3	2026-07-01	current	Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg	yes

J0701 Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mg
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg
J0703 Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to maxipime, 500 mg
J0706 Injection, caffeine citrate, 5 mg
J0712 Injection, ceftaroline fosamil, 10 mg
J0713 Injection, ceftazidime, per 500 mg
J0714 Injection, ceftazidime and avibactam, 0.5 g/0.125 g
J0716 Injection, centruroides immune f(ab)2, up to 120 milligrams
J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
J0720 Injection, chloramphenicol sodium succinate, up to 1 gm
J0725 Injection, chorionic gonadotropin, per 1,000 usp units
J0735 Injection, clonidine hydrochloride, 1 mg
J0736 Injection, clindamycin phosphate, 300 mg
J0738 Injection, lenacapavir, 1 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)
J0739 Injection, cabotegravir, 1mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)
J0740 Injection, cidofovir, 375 mg
J0741 Injection, cabotegravir and rilpivirine, 2mg/3mg
J0742 Injection, imipenem 4 mg, cilastatin 4 mg and relebactam 2 mg
J0743 Injection, cilastatin sodium; imipenem, per 250 mg
J0744 Injection, ciprofloxacin for intravenous infusion, 200 mg